Wearable devices have transitioned from fitness trackers to sophisticated health monitors capable of detecting early signs of infectious diseases. By continuously measuring physiological parameters, these devices offer a non-invasive, real-time window into the body’s response to pathogens. The potential to identify infections before symptoms become severe—or even before the individual feels ill—could transform public health surveillance, enabling rapid containment and personalized treatment. This article explores the engineering behind these devices, the challenges they face, and the future of wearable diagnostics.

The Role of Wearables in Infectious Disease Surveillance

Traditional infectious disease detection relies on laboratory-based tests such as PCR, antigen assays, or serology. While accurate, these methods require specialized equipment, trained personnel, and a biological sample—often blood, saliva, or a nasal swab. Results can take hours to days, and access is limited in rural or low-resource settings. Wearable devices, by contrast, offer passive, continuous collection of health data without interrupting daily life. This capability is especially valuable for early outbreak detection, monitoring asymptomatic carriers, and tracking recovery in real time.

During the COVID-19 pandemic, research groups rapidly pivoted to evaluate whether consumer smartwatches could predict infection days before standard tests turned positive. Studies from institutions such as Stanford University and the Nature Digital Medicine group demonstrated that changes in resting heart rate, heart rate variability, and skin temperature often precede symptoms. These findings have accelerated investment in wearable diagnostics for a range of infectious diseases, including influenza, RSV, and emerging zoonotic threats.

Continuous Monitoring vs. Traditional Diagnostics

The fundamental advantage of wearables is temporal resolution. A wearable collects thousands of data points per day, creating a personalized baseline. Any deviation—whether a spike in nocturnal heart rate, a drop in oxygen saturation, or an increase in respiratory rate—can trigger an alert. Traditional diagnostics provide a snapshot at a single point in time, which may miss early or intermittent signals. Combining wearable data with occasional confirmatory tests could create a powerful hybrid surveillance system.

Moreover, wearables reduce the burden on healthcare systems by enabling triage before clinic visits. If a device flags a likely infection, the user can be directed to testing or telemedicine. This approach was piloted during the pandemic by the CDC in partnership with device manufacturers, demonstrating the feasibility of population-level screening.

Key Physiological Signals and Biomarkers

Wearable devices detect infections by monitoring physiological signals that change in response to immune activation. The most commonly measured indicators include heart rate, respiratory rate, body temperature, skin conductance, and—less commonly—biochemical markers.

Heart Rate and Respiratory Rate

Infections trigger systemic inflammation, which elevates resting heart rate and reduces heart rate variability. Many consumer wearables (e.g., Apple Watch, Fitbit, Garmin) use photoplethysmography (PPG) to measure heart rate. Respiratory rate can be derived from accelerometer data or PPG signal variations. Algorithms trained on these features have shown sensitivity of 70–90% for detecting COVID-19 infection 1–3 days before symptom onset, according to studies published in JAMA Network Open and Nature Biomedical Engineering.

Body Temperature and Skin Conductance

Fever is a hallmark of many infectious diseases. Wearables with skin temperature sensors can track deviations from an individual’s norm. Continuous temperature monitoring is more informative than sporadic thermometer readings because it reveals circadian patterns. Skin conductance—measured via electrodes on a wristband or patch—reflects stress and immune activation through changes in sweat gland activity.

Some advanced prototypes combine temperature and conductance to differentiate between bacterial and viral infections, though this remains an active research area. A recent Science Advances paper described a wearable patch that measures both temperature and a biomarker for inflammation (C-reactive protein) in interstitial fluid.

Biochemical Markers via Sweat and Interstitial Fluid

The next frontier is real-time detection of specific biomarkers—such as viral proteins, antibodies, or cytokines—using sweat or interstitial fluid. Microneedle patches and microfluidic sweat sensors can sample these fluids non-invasively. For example, researchers have developed wearable amperometric sensors that detect antigens from influenza and SARS-CoV-2 in sweat within minutes. These devices integrate flexible electrodes coated with antibodies that produce a measurable electrical signal when the target binds.

Engineering such sensors requires balancing sensitivity, selectivity, and stability. The biomarker concentrations in sweat are often very low (nanomolar or picomolar), and interference from other sweat components must be minimized. Recent advances in nanomaterials—such as graphene, carbon nanotubes, and gold nanoparticles—have improved detection limits to clinically relevant ranges.

Engineering Wearable Sensors for Infection Detection

Developing a wearable that is both clinically accurate and user-friendly presents a set of interconnected engineering challenges. Four primary areas dominate the research landscape: sensor sensitivity and specificity, power management, data processing and privacy, and user comfort.

Sensor Sensitivity and Specificity

For early detection, sensors must reliably identify subtle physiological changes that occur during the incubation period. False positives can cause unnecessary anxiety and healthcare strain; false negatives can undermine trust and delay treatment. Achieving high sensitivity often requires combining multiple signals (e.g., heart rate + temperature + activity) using machine learning models. For biochemical sensors, the challenge is maintaining antibody or aptamer functionality during continuous wear—proteins can denature, and sensor surfaces can foul.

One promising approach is the use of genetically engineered living cells embedded in a hydrogel patch that fluoresce in the presence of specific pathogens. Such “living sensors” are still experimental but demonstrate the creative strategies being pursued.

Power Management and Energy Harvesting

Continuous monitoring drains batteries quickly. A device that needs daily charging may be abandoned by users, disrupting the data stream needed for infection surveillance. Engineers are exploring low-power electronics, sleep modes that only activate when thresholds are exceeded, and energy-harvesting techniques such as thermoelectric generators (using body heat) or piezoelectric materials (using motion). Some prototypes can run for weeks on a single charge by offloading heavy computation to a smartphone or cloud server.

Alternatively, passive wearables that require no internal battery—e.g., near-field communication (NFC) patches that are powered when tapped by a smartphone—offer a solution for short-term monitoring, such as during an outbreak hot zone.

Data Transmission and Privacy

Wearable health data is highly sensitive. Engineering secure transmission and storage is critical. Many devices rely on Bluetooth Low Energy (BLE) or Wi-Fi to send data to a smartphone, which then uploads to a cloud platform. End-to-end encryption, local processing to minimize cloud exposure, and anonymization techniques are standard in research-grade systems. However, commercial devices vary in their privacy policies, and regulatory frameworks like HIPAA (in the US) and GDPR (in Europe) impose strict requirements.

For population-level surveillance, aggregated anonymized data can provide early outbreak signals without compromising individual privacy. For instance, a spike in elevated resting heart rates across a geographic region could be a leading indicator of a respiratory illness outbreak.

Notable Examples and Research Breakthroughs

Several real-world implementations and clinical studies demonstrate the potential of wearable devices for infectious disease detection.

Smartwatch Algorithms for Pre-Symptomatic COVID-19 Detection

Stanford University’s Wearable Tech Lab published a landmark study in 2021 showing that the Apple Watch could detect COVID-19 up to 7 days before a PCR-positive test. The algorithm used heart rate variability, resting heart rate, and steps—collected continuously before symptom onset. A larger follow-up study, involving 30,000 participants across multiple device brands, confirmed that combining heart rate, sleep, and activity data improved prediction accuracy to over 80%.

Similar efforts by the University of California, San Diego, and the DARPA-funded “Warfighter Analytics” program have validated that wearables can detect influenza and other respiratory infections with comparable lead times.

Wearable Patch for Influenza and RSV

A team from Northwestern University developed a soft, flexible patch that adheres to the skin and monitors temperature, respiratory rate, and cough sounds via a microphone. In a 2022 pilot study, the patch correctly identified influenza or RSV infections in children 2 days earlier than parents noticed symptoms. The patch communicates wirelessly with a smartphone app and sends alerts to caregivers. This device is now being scaled for manufacturing by a medical device startup.

The patch represents a shift from wrist-worn devices to more unobtrusive body-worn sensors that can capture a wider range of signals. Researchers are also experimenting with smart textiles—shirts with integrated conductive fibers that measure respiration and heart rate—for hospital ward monitoring.

Challenges in Deployment and Adoption

Despite promising results, several hurdles prevent widespread deployment of wearable infectious disease detectors.

User Compliance and Comfort

Continuous wear can cause skin irritation, especially in hot or humid conditions. Devices must be waterproof, durable, and comfortable for 24/7 use. In low-resource settings, affordability is a major barrier. While smartwatches cost hundreds of dollars, disposable paper-based sweat sensors or simple armband monitors could be produced for under $5 each. However, those simpler sensors lack the computational power to run complex algorithms locally.

Adherence also depends on perceived benefit. Users are more likely to wear a device if they know it can detect a serious infection early. Public health campaigns that demonstrate the value—especially for vulnerable populations—can improve uptake.

Regulatory Approval and Clinical Validation

Most wearable devices are classified as wellness or fitness products, not medical devices, to avoid stringent FDA or CE-Mark requirements. However, claiming the ability to detect or diagnose an infection automatically categorizes the device as a medical device requiring clinical trials. The regulatory pathway is expensive and time-consuming, often deterring startups. Even after approval, post-market surveillance is needed to ensure accuracy across different demographics and skin tones—a well-documented issue with pulse oximetry.

The World Health Organization has emphasized the need for equitable validation across geographies. A device calibrated on young, healthy subjects in a temperate climate may perform poorly on elderly individuals in tropical regions. Multi-site studies with diverse populations are essential.

Future Directions: AI, Nanotechnology, and Flexible Electronics

The next generation of wearable diagnostic devices will integrate artificial intelligence that runs on-device, reducing latency and enhancing privacy. Edge AI chips can analyze PPG signals in real time, adjusting sensor thresholds without uploading raw data to the cloud. This enables personalized models that adapt to each user’s baseline.

Nanotechnology will allow the creation of high-specificity biosensors using engineered nanoparticles. For example, quantum dots or gold nanorods can change color or fluoresce when binding to viral antigens, detectable by a photodiode. Such optical sensors are less prone to drift than electrochemical sensors.

Flexible, stretchable electronics will make wearables more like a second skin. Researchers have already demonstrated “electronic tattoos” that attach to the chest and measure temperature, respiration, and even vocal strain. When combined with a microfluidic channel for sweat collection, these tattoos can perform multiplexed biomarker assays.

Finally, machine learning models trained on large-scale wearable datasets will improve predictive power. These models must account for confounding factors (exercise, stress, climate) to isolate infection signals. Collaborative initiatives like the New York State Department of Health’s wearable data-sharing platform are building the infrastructure needed for such analysis.

Conclusion

Engineering wearable devices for early detection of infectious diseases holds transformative potential for global health. By continuously harvesting physiological and biochemical data, these devices can provide a early warning system that enables swift intervention and containment. Real-world studies with smartwatches and patches have demonstrated lead times of days before symptoms or positive lab tests, offering a window for action. However, challenges in sensor reliability, power, privacy, and regulatory approval must be addressed. Innovations in nanomaterials, flexible electronics, and on-device AI are rapidly closing the gap between prototype and product. With sustained interdisciplinary collaboration, wearable diagnostics could become a cornerstone of pandemic preparedness and routine infection management, saving lives and reducing the burden on healthcare systems worldwide.